These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related]
7. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Friemann S; Feuring E; Padberg W; Ernst W Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504 [No Abstract] [Full Text] [Related]
8. Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study. Yuan QS; Zheng FL; Sun Y; Yu Y; Li Y Transplant Proc; 2000 Nov; 32(7):1694-5. PubMed ID: 11119896 [No Abstract] [Full Text] [Related]
9. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Neal DA; Gimson AE; Gibbs P; Alexander GJ Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583 [TBL] [Abstract][Full Text] [Related]
10. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. Colak T; Karakayali H; Yagmurdur MC; Moray G Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321 [No Abstract] [Full Text] [Related]
11. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients. Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359 [No Abstract] [Full Text] [Related]
12. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. Wiesner RH Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565 [No Abstract] [Full Text] [Related]
14. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy. Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553 [No Abstract] [Full Text] [Related]
15. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. Arnold JC; Theilmann L Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559 [No Abstract] [Full Text] [Related]
16. Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin. Aguirrezabalaga J; Fernandez-Selles C; Fraguela J; Otero A; Suarez F; Gómez M Transplant Proc; 2002 Aug; 34(5):1551-2. PubMed ID: 12176480 [No Abstract] [Full Text] [Related]
17. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the switch to tacrolimus in liver transplantation. González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653 [No Abstract] [Full Text] [Related]
19. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510 [No Abstract] [Full Text] [Related]
20. Conversion to tacrolimus in hyperlipidemic patients. Friemann S; Stopp K; Christ B; Weimer R; Padberg W; Ernst W Transplant Proc; 1999 Nov; 31(7A):41S-43S. PubMed ID: 10576042 [No Abstract] [Full Text] [Related] [Next] [New Search]